Europe Breast Implant Market Size and Share
| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 584.32 Million |
| Market Size (2030) | USD 815.71 Million |
| CAGR (2025 - 2030) | 6.90% |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Breast Implant Market Analysis by Mordor Intelligence
The Europe Breast Implant Market size is estimated at USD 584.32 million in 2025, and is expected to reach USD 815.71 million by 2030, at a CAGR of 6.90% during the forecast period (2025-2030).
Factors such as the rising incidence of breast cancer, technological advancements, and the increasing number of breast augmentation procedures are expected to boost market growth.
The rising prevalence of breast cancer in European countries is a major factor driving the market’s growth, as it is expected to boost the usage of breast implants during breast reconstruction. For instance, according to the data updated by the European Commission in October 2022, breast cancer remained one the most diagnosed cancers in the European Union, with an estimated 380,000 cases (99% of these affected women) in 2022, which constituted 13.8% of all cancer diagnoses in Europe in 2022. Hence, the high prevalence of breast cancer is expected to drive the adoption of breast implants , driving the growth of the market.
The growing burden of breast cancer in various countries around Europe is anticipated to drive the demand for breast implants, as they are often used during breast augmentation procedures after surgery. For instance, according to an article published by the Journal of Breast Cancer Research and Treatment in July 2023, a study was conducted in Europe that showed that breast cancer was diagnosed more at older ages in 2022 in Germany. In addition, the proportion of breast cancer cases in the age group 50-65 increased in gynecological practices in Germany in 2022. Therefore, the rising prevalence of breast cancer is also expected to boost the market’s growth.
The rising number of breast augmentation procedures is also positively affecting the growth of the market. For instance, according to the data updated by the International Society of Aesthetic Plastic Surgery (ISAPS) in June 2024, an estimated 38.9 thousand breast augmentation procedures were conducted in Italy in 2023. Thus, owing to such a high number of breast augmentation procedures, the market is expected to record significant growth over the forecast period.
Owing to the aforementioned factors, such as the rising prevalence of breast cancer and the rising number of breast augmentation procedures, the market is anticipated to grow over the forecast period. However, the high cost of breast implants and the complications and risks associated with breast implants are likely to impede market growth.
Europe Breast Implant Market Trends and Insights
The Silicone Implants Segment is Expected to Witness Significant Growth Over the Forecast Period
Silicone implants are made of silicone shells filled with a gel that mimics the viscosity of human fat. These implants are primarily used for breast augmentation and reconstruction. Their natural feel, akin to breast tissue, sets them apart from other implant types, making them the top choice for many seeking augmentation. The major factors driving the growth of the segment include the rising burden of breast cancer, the growing technological advancements in silicone implants, and the rising use of silicone implants during breast augmentation.
The increasing burden of breast cancer is a major factor driving the growth of the market. For instance, according to the cancer statistics published by the Italian Association of Cancer Registries (AIRTUM) in 2022, there were around 391,000 new cancer diagnoses in 2022 in Italy, out of which 14.3% were breast cancer. Thus, owing to the high prevalence of breast cancer cases in Italy, the need for silicone breast implants is likely to rise, leading to segmental growth over the forecast period.
The rising geriatric population is considered a major driver for the segment's growth as this population is more prone to breast cancer. For instance, according to the report published by Eurostat in February 2024, the European population was estimated at 448.8 million people in 2023, and 21.3 % of the total population was aged 65 years and over. The risk of breast cancer increases with age, and this is anticipated to boost the market’s growth.
Hence, the aforementioned factors, such as the rising prevalence of breast cancer and the rising geriatric population, are expected to boost the segment’s growth during the forecast period.
Spain is Expected to Hold a Significant Share of the Market
Spain is expected to hold a significant share of the market owing to factors such as the easy availability of technologically advanced products and the increase in the adoption of breast implants. Moreover, the rising prevalence of breast cancer and the increasing geriatric population in the country are also among the key factors that contribute to the growth of the market in Spain.
For instance, according to the data published by REDECAN in 2023, an estimated 35,001 people were expected to be diagnosed with breast cancer in Spain in 2023. Thus, with the increasing burden of breast cancer across the country, the segment is expected to witness strong growth.
The rising number of breast augmentation procedures is also positively affecting the growth of the market. For instance, according to the data updated by the International Society of Aesthetic Plastic Surgery (ISAPS) in June 2024, an estimated 44.7 thousand breast augmentation procedures were conducted in Spain in 2023. Thus, owing to such high numbers of breast augmentation procedures, the market is expected to record significant growth over the forecast period.
Therefore, owing to the aforementioned factors, such as the high prevalence of breast cancer and the large number of breast augmentation procedures, the growth of the market is anticipated in Spain.
Competitive Landscape
The European breast implant market is fragmented due to the presence of several local as well as international companies. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market shares and are well known. Some of the key market players include AbbVie Inc. (Allergan PLC), Establishment Labs SA, GC Aesthetics, Sebbin, Laboratories Arion, and Johnson & Johnson.
Europe Breast Implant Industry Leaders
-
AbbVie Inc. (Allergan PLC)
-
GC Aesthetics
-
Sebbin
-
Laboratories Arion
-
Johnson & Johnson
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- April 2024: GC Aesthetics (GCA) launched a micro-textured anatomical breast implant LUNA XT. The company mentioned that it was one of the first breast implants in the world approved under the new European Medical Device Regulation (MDR).
- August 2023: The United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA) published guidance on the risk of lymphoma in recipients of breast implants. MHRA issued recommendations for patients and healthcare professionals after reviewing a few implant-related lymphomas.
Europe Breast Implant Market Report Scope
Breast implants are medical devices used to augment the size of breasts, either for cosmetic applications or reconstruction purposes or to correct a congenital abnormality. The procedure involves the usage of breast implants to enhance and improve the size of the breasts.
The European breast implant market is segmented by type, application, end user, and geography. By type, the market is segmented into silicone implants, form-stable implants, and saline implants. By application, the market is segmented into reconstructive surgery and cosmetic surgery. By end user, the market is segmented into hospitals, cosmetology clinics, and other end users. By geography, the market is segmented into Germany, the United Kingdom, France, Italy, Spain, and Rest of Europe. The report offers the value (USD) for all the above segments.
| Silicone Implants |
| Form-stable Implants |
| Saline Implants |
| Reconstructive Surgery |
| Cosmetic Surgery |
| Hospital |
| Cosmetology Clinic |
| Other End-users |
| Germany |
| United Kingdom |
| France |
| Italy |
| Spain |
| Rest of Europe |
| By Type | Silicone Implants |
| Form-stable Implants | |
| Saline Implants | |
| By Application | Reconstructive Surgery |
| Cosmetic Surgery | |
| By End User | Hospital |
| Cosmetology Clinic | |
| Other End-users | |
| By Geography | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe |
Key Questions Answered in the Report
How big is the Europe Breast Implant Market?
The Europe Breast Implant Market size is expected to reach USD 584.32 million in 2025 and grow at a CAGR of 6.90% to reach USD 815.71 million by 2030.
What is the current Europe Breast Implant Market size?
In 2025, the Europe Breast Implant Market size is expected to reach USD 584.32 million.
Who are the key players in Europe Breast Implant Market?
AbbVie Inc. (Allergan PLC), GC Aesthetics, Sebbin, Laboratories Arion and Johnson & Johnson are the major companies operating in the Europe Breast Implant Market.
What years does this Europe Breast Implant Market cover, and what was the market size in 2024?
In 2024, the Europe Breast Implant Market size was estimated at USD 544.00 million. The report covers the Europe Breast Implant Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Breast Implant Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Europe Breast Implant Market Report
Statistics for the 2025 Europe Breast Implant market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Breast Implant analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
